Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Change in Acquisitions & Divestments (2022 - 2025)

AVITA Medical (RCEL) has disclosed Change in Acquisitions & Divestments for 4 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 80.0% year-over-year to $2.0 million, compared with a TTM value of $27.5 million through Dec 2025, down 61.38%, and an annual FY2025 reading of $27.5 million, down 61.38% over the prior year.
  • Change in Acquisitions & Divestments was $2.0 million for Q4 2025 at AVITA Medical, down from $3.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $24.3 million in Q1 2023 and bottomed at -$43.0 million in Q3 2023.
  • Average Change in Acquisitions & Divestments over 4 years is $10.4 million, with a median of $11.9 million recorded in 2022.
  • Peak annual rise in Change in Acquisitions & Divestments hit 709.03% in 2023, while the deepest fall reached 335.98% in 2023.
  • Year by year, Change in Acquisitions & Divestments stood at $11.9 million in 2022, then plummeted by 461.9% to -$43.0 million in 2023, then skyrocketed by 123.25% to $10.0 million in 2024, then crashed by 80.0% to $2.0 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for RCEL at $2.0 million in Q4 2025, $3.5 million in Q3 2025, and $11.0 million in Q2 2025.